image
ImmuCell Corporation ICCC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 5.42
-2.18 %
$ 48.7 M
Market Cap
-20.69
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
--27.53%
EBIT Estimate
--19.36%
Net Income Estimate
58.35%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets ImmuCell Corporation
image
ICCC has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart ICCC

image
$30.0m$30.0m$25.0m$25.0m$20.0m$20.0m$15.0m$15.0m$10.0m$10.0m$5.0m$5.0m$0.0$0.0202020202021202120232023202420242025202520262026
EBIT FORECAST

EBIT Forecast Chart ICCC

image
$3.0m$3.0m$2.0m$2.0m$1.0m$1.0m$0.0$0.0($1.0m)($1.0m)($2.0m)($2.0m)($3.0m)($3.0m)($4.0m)($4.0m)($5.0m)($5.0m)($6.0m)($6.0m)202020202021202120232023202420242025202520262026
NET INCOME FORECAST

Net Income Chart ICCC

image
$2.0m$2.0m$1.0m$1.0m$0.0$0.0($1.0m)($1.0m)($2.0m)($2.0m)($3.0m)($3.0m)($4.0m)($4.0m)($5.0m)($5.0m)($6.0m)($6.0m)202020202021202120232023202420242025202520262026